Table 3.
Predictive Factors for Recurrence
| Variable | Univariate analysis | Multivariate analysis | ||||
|---|---|---|---|---|---|---|
|
|
|
|||||
| HR | 95% CI | p-value | HR | 95% CI | p-value | |
| Age (>60 yr) | 0.595 | 0.290–1.222 | 0.157 | |||
| Male sex | 0.502 | 0.234–1.073 | 0.075 | |||
| HBV | 2.053 | 0.712–5.922 | 0.183 | |||
| HCV | 2.328 | 0.680–7.969 | 0.178 | |||
| Liver cirrhosis | 1.188 | 0.458–3.083 | 0.723 | |||
| MELD score (>10) | 0.556 | 0.133–2.326 | 0.422 | |||
| CTP score (A/B, C) | 1.127 | 0.551–2.306 | 0.743 | |||
| AFP (>20 ng/mL) | 2.544 | 1.285–5.036 | 0.007 | 2.220 | 1.098–4.488 | 0.026 |
| Tumor size (>5 cm) | 1.167 | 0.452–3.015 | 0.750 | |||
| Nodularity (multinodular) | 5.487 | 2.725–11.047 | <0.001 | 5.143 | 2.532–10.444 | <0.001 |
| Portal vein thrombosis | 1.335 | 0.319–5.588 | 0.693 | |||
HR, hazard ratio; CI, confidence interval; HBV, hepatitis B virus; HCV, hepatitis C virus; MELD, model for end-stage liver disease; CTP, Child-Turcotte-Pugh; AFP, α-fetoprotein.